Oxford BioMedica plc Company Profile (LON:OXB)

About Oxford BioMedica plc (LON:OXB)

Oxford BioMedica plc logoOxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company's segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners. The R&D segment is engaged in the development of in-vivo and ex-vivo gene and cell therapy products, and the development of lentivirus-related platform technology. The Company provides a platform of technologies and capabilities with which it designs, develops and produces gene and cell-based medicines. The Company's product pipeline of OXB-102, OXB-201, OXB-202 and OXB-302 addresses neurodegenerative and ocular diseases, and a range of cancers. OXB-102 is indicated for Parkinson's disease. OXB-202 is indicated for Ocular (corneal graft rejection). OXB-302 is indicated for cancer disease. Its OXB-201 is indicated for wet age-related macular degeneration.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: LON:OXB
  • CUSIP: N/A
  • Web: www.oxfordbiomedica.co.uk
  • Market Cap: £265.39 million
  • Outstanding Shares: 3,040,000,000
Average Prices:
  • 50 Day Moving Avg: GBX 8.92
  • 200 Day Moving Avg: GBX 5.90
  • 52 Week Range: GBX 2.98 - GBX 11.50
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: £30.99 million
  • Price / Sales: 8.56
  • Book Value: N/A
  • Price / Book: N/A
  • EBIDTA: ($2,220,000.00)
  • Net Margins: -47.43%
  • Return on Equity: -132.12%
  • Return on Assets: -26.08%
  • Average Volume: 11.79 million shs.

Frequently Asked Questions for Oxford BioMedica plc (LON:OXB)

What is Oxford BioMedica plc's stock symbol?

Oxford BioMedica plc trades on the London Stock Exchange (LON) under the ticker symbol "OXB."

Where is Oxford BioMedica plc's stock going? Where will Oxford BioMedica plc's stock price be in 2017?

2 analysts have issued twelve-month price objectives for Oxford BioMedica plc's stock. Their predictions range from GBX 8.70 to GBX 13. On average, they anticipate Oxford BioMedica plc's share price to reach GBX 10.85 in the next twelve months. View Analyst Ratings for Oxford BioMedica plc.

Who are some of Oxford BioMedica plc's key competitors?

Who are Oxford BioMedica plc's key executives?

Oxford BioMedica plc's management team includes the folowing people:

  • John Dawson, Chief Executive Officer, Executive Director
  • Tim Watts, Chief Financial Officer, Company Secretary, Executive Director
  • Peter Nolan, Executive Director, Chief Business Officer
  • Lorenzo Tallarigo M.D., Non-Executive Chairman of the Board
  • Andrew J. Heath M.D., Ph.D., Non-Executive Deputy Chairman of the Board, Senior Independent Director
  • Martin Diggle, Non-Executive Director
  • Stuart Henderson, Non-Executive Director

How do I buy Oxford BioMedica plc stock?

Shares of Oxford BioMedica plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Oxford BioMedica plc's stock price today?

One share of Oxford BioMedica plc stock can currently be purchased for approximately GBX 8.73.

MarketBeat Community Rating for Oxford BioMedica plc (LON OXB)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  98 (Vote Outperform)
Underperform Votes:  75 (Vote Underperform)
Total Votes:  173
MarketBeat's community ratings are surveys of what our community members think about Oxford BioMedica plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Oxford BioMedica plc (LON:OXB) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: GBX 10.85

Analysts' Ratings History for Oxford BioMedica plc (LON:OXB)
DateFirmActionRatingPrice TargetDetails
7/27/2017N+1 SingerBoost Price TargetHoldGBX 7.80 -> GBX 8.70View Rating Details
7/13/2017Shore CapitalReiterated Ratingnot ratedView Rating Details
7/13/2017Jefferies Group LLCReiterated RatingBuyGBX 13View Rating Details
(Data available from 8/20/2015 forward)


Earnings History for Oxford BioMedica plc (LON:OXB)
Earnings by Quarter for Oxford BioMedica plc (LON:OXB)
Earnings History by Quarter for Oxford BioMedica plc (LON OXB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/11/2017S1 2017$0.00$0.00N/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Oxford BioMedica plc (LON:OXB)
Current Year EPS Consensus Estimate: $-0.21 EPS


Dividend History for Oxford BioMedica plc (LON:OXB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Oxford BioMedica plc (LON:OXB)
Insider Trades by Quarter for Oxford BioMedica plc (LON:OXB)
Insider Trades by Quarter for Oxford BioMedica plc (LON:OXB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/17/2017Peter NolanInsiderBuy249,687GBX 8£19,974.96
7/13/2017Martin DiggleInsiderBuy660,000GBX 9£59,400
6/23/2017Lorenzo TallarigoInsiderBuy49,033GBX 5£2,451.65
5/24/2017Lorenzo TallarigoInsiderBuy53,260GBX 5£2,663
4/24/2017Lorenzo TallarigoInsiderBuy54,090GBX 5£2,704.50
3/23/2017Lorenzo TallarigoInsiderBuy49,468GBX 5£2,473.40
2/24/2017Lorenzo TallarigoInsiderBuy67,165GBX 4£2,686.60
12/15/2016Lorenzo TallarigoInsiderBuy65,993GBX 4£2,639.72
11/25/2016Lorenzo TallarigoInsiderBuy75,417GBX 4£3,016.68
10/25/2016Lorenzo TallarigoInsiderBuy77,864GBX 3£2,335.92
9/26/2016Lorenzo TallarigoInsiderBuy79,988GBX 3£2,399.64
8/25/2016Tallarigo ,LorenzoInsiderBuy62,257GBX 4£2,490.28
7/25/2016Tallarigo ,LorenzoInsiderBuy63,351GBX 4£2,534.04
6/24/2016Tallarigo ,LorenzoInsiderBuy62,847GBX 4£2,513.88
5/13/2016Diggle ,MartinInsiderBuy42,072GBX 5£2,103.60
5/12/2016Diggle ,MartinInsiderBuy45,428GBX 5£2,271.40
5/5/2016Diggle ,MartinInsiderBuy12,500GBX 6£750
5/4/2016Diggle ,MartinInsiderBuy44,689GBX 6£2,681.34
5/3/2016Diggle ,MartinInsiderBuy317,382GBX 6£19,042.92
4/29/2016Nolan,PeterInsiderBuy359,925GBX 6£21,595.50
4/22/2016Tallarigo ,LorenzoInsiderBuy41,083GBX 6£2,464.98
3/24/2016Tallarigo ,LorenzoInsiderBuy41,550GBX 6£2,493
2/26/2016Diggle ,MartinInsiderBuy29,345GBX 7£2,054.15
2/25/2016Tallarigo ,LorenzoInsiderBuy36,370GBX 7£2,545.90
2/24/2016Diggle ,MartinInsiderBuy46,693GBX 6£2,801.58
7/1/2015Diggle ,MartinInsiderBuy284,439GBX 0.09£256
6/30/2015Diggle ,MartinInsiderBuy775,000GBX 0.09£697.50
6/19/2015Diggle ,MartinInsiderBuy225,000GBX 0.08£180
6/12/2015Martin DiggleInsiderBuy283,978GBX 9.01£25,586.42
6/11/2015Martin DiggleInsiderBuy416,022GBX 9£37,441.98
6/9/2015Daniel SolandInsiderBuy500,000GBX 9.45£47,250
5/21/2015Andrew HeathInsiderBuy100,000GBX 10.60£10,600
5/19/2015Tim WattsInsiderBuy194,174GBX 10.30£19,999.92
(Data available from 1/1/2013 forward)


Headline Trends for Oxford BioMedica plc (LON:OXB)
Latest Headlines for Oxford BioMedica plc (LON:OXB)
americanbankingnews.com logoOxford BioMedica plc (LON:OXB) Given New GBX 8.70 Price Target at N+1 Singer
www.americanbankingnews.com - July 27 at 11:22 AM
americanbankingnews.com logoPeter Nolan Buys 249,687 Shares of Oxford BioMedica plc (LON:OXB) Stock
www.americanbankingnews.com - July 17 at 11:29 AM
americanbankingnews.com logoInsider Buying: Oxford BioMedica plc (OXB) Insider Buys 660,000 Shares of Stock
www.americanbankingnews.com - July 14 at 1:56 PM
americanbankingnews.com logoOxford BioMedica plc's (LON:OXB) "Not Rated" Rating Reaffirmed at Shore Capital
www.americanbankingnews.com - July 13 at 3:10 PM
americanbankingnews.com logoOxford BioMedica plc (LON:OXB) Stock Rating Reaffirmed by N+1 Singer
www.americanbankingnews.com - July 9 at 7:30 AM
americanbankingnews.com logoOxford BioMedica plc (OXB) Insider Acquires £2,451.65 in Stock
www.americanbankingnews.com - June 26 at 7:40 AM
finance.yahoo.com logoOxford BioMedica plc: Oxford BioMedica notes FDA Advisory Committee to review CTL019
finance.yahoo.com - June 7 at 6:57 PM
ft.com logoInvestors Chronicle: Bellway, M&C Saatchi, Oxford Biomedica - Financial Times
www.ft.com - March 25 at 8:51 AM
ft.com logo[$$] Investors Chronicle: Bellway, M&C Saatchi, Oxford Biomedica
www.ft.com - March 24 at 6:58 PM
americanbankingnews.com logoOxford BioMedica plc (OXB) Insider Lorenzo Tallarigo Purchases 49,468 Shares
www.americanbankingnews.com - March 24 at 10:08 AM
seekingalpha.com logoOxford BioMedica's (OXBDF) CEO John Dawson on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - March 17 at 12:52 AM
americanbankingnews.com logoOxford BioMedica plc (OXB) Earns “Hold” Rating from N+1 Singer
www.americanbankingnews.com - March 16 at 8:27 PM
reuters.com logoUK STOCKS-Factors to watch on March 16
www.reuters.com - March 16 at 8:44 AM
biz.yahoo.com logoFull Year 2016 Oxford BioMedica PLC Earnings Release - Before Market Open
biz.yahoo.com - March 16 at 8:44 AM
americanbankingnews.com logoOxford BioMedica plc (OXB) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - March 15 at 3:40 AM
lse.co.uk logoDirector Dealings / Market Share Purchase - London South East (registration) (blog)
www.lse.co.uk - January 25 at 5:56 AM
lse.co.uk logoFindings Reported by Novartis on CTL-019 at ASH - London South East (registration) (blog)
www.lse.co.uk - December 5 at 7:03 PM
lse.co.uk logoResult of General Meeting and Directors Dealing - London South East (registration) (blog)
www.lse.co.uk - September 30 at 6:43 PM


Social activity is not available for this stock.


Oxford BioMedica plc (OXB) Chart for Sunday, August, 20, 2017

This page was last updated on 8/20/2017 by MarketBeat.com Staff